Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion type Assertion NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_head.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion wasGeneratedBy ECO_0000203 NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion wasDerivedFrom befree-2016 NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion SIO_000772 16300471 NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion evidence source_evidence_literature NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.
- NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_assertion description "[As Ubc9 is the sole E2-conjugating enzyme required for sumoylation, and, in particular, Ubc9 is upregulated in an increasing number of human malignancies, such as ovarian carcinoma, melanoma and lung adenocarcinoma, it is a potential target for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523377.RAbUT6LOWGcs9cT9xt7qUhWE2JV7NPFZbqjqF-v-_eL1k130_provenance.